Association Between Circulating White Blood Cell Count and Cancer Mortality: A Population-Based Cohort Study | Anticoagulation | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.186.91. Please contact the publisher to request reinstatement.
1.
Coussens  LMWerb  Z Inflammation and cancer.  Nature 2002;420860- 867PubMedGoogle ScholarCrossref
2.
Balkwill  FCoussens  LM Cancer: an inflammatory link.  Nature 2004;431405- 406PubMedGoogle ScholarCrossref
3.
Grimm  RH  JrNeaton  JDLudwig  W Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality.  JAMA 1985;2541932- 1937PubMedGoogle ScholarCrossref
4.
Yano  KGrove  JSChen  RRodriguez  BLCurb  JDTracy  RP Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American men.  Arterioscler Thromb Vasc Biol 2001;211065- 1070PubMedGoogle ScholarCrossref
5.
Friedman  GDFireman  BH The leukocyte count and cancer mortality.  Am J Epidemiol 1991;133376- 380PubMedGoogle Scholar
6.
Ko  WFHelzlsouer  KJComstock  GW Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer.  J Natl Cancer Inst 1994;861874- 1875PubMedGoogle ScholarCrossref
7.
Erlinger  TPPlatz  EARifai  NHelzlsouer  KJ C-reactive protein and the risk of incident colorectal cancer.  JAMA 2004;291585- 590PubMedGoogle ScholarCrossref
8.
Zhang  SMBuring  JELee  IMCook  NRRidker  PM C-reactive protein levels are not associated with increased risk for colorectal cancer in women.  Ann Intern Med 2005;142425- 432PubMedGoogle ScholarCrossref
9.
Erlinger  TPMuntner  PHelzlsouer  KJ WBC count and the risk of cancer mortality in a national sample of US adults: results from the Second National Health and Nutrition Examination Survey mortality study.  Cancer Epidemiol Biomarkers Prev 2004;131052- 1056PubMedGoogle Scholar
10.
Nakanishi  NYoshida  HMatsuo  YSuzuki  KTatara  K White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men.  Diabetologia 2002;4542- 48PubMedGoogle ScholarCrossref
11.
Vozarova  BWeyer  CLindsay  RSPratley  REBogardus  CTataranni  PA High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.  Diabetes 2002;51455- 461PubMedGoogle ScholarCrossref
12.
Pradhan  ADManson  JERifai  NBuring  JERidker  PM C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.  JAMA 2001;286327- 334PubMedGoogle ScholarCrossref
13.
Saydah  SHLoria  CMEberhardt  MSBrancati  FL Abnormal glucose tolerance and the risk of cancer death in the United States.  Am J Epidemiol 2003;1571092- 1100PubMedGoogle ScholarCrossref
14.
Gapstur  SMGann  PHColangelo  LA  et al.  Postload plasma glucose concentration and 27-year prostate cancer mortality (United States).  Cancer Causes Control 2001;12763- 772PubMedGoogle ScholarCrossref
15.
Jee  SHOhrr  HSull  JWYun  JEJi  MSamet  JM Fasting serum glucose level and cancer risk in Korean men and women.  JAMA 2005;293194- 202PubMedGoogle ScholarCrossref
16.
Giovannucci  EEgan  KMHunter  DJ  et al.  Aspirin and the risk of colorectal cancer in women.  N Engl J Med 1995;333609- 614PubMedGoogle ScholarCrossref
17.
Harris  RENamboodiri  KKFarrar  WB Nonsteroidal antiinflammatory drugs and breast cancer.  Epidemiology 1996;7203- 205PubMedGoogle ScholarCrossref
18.
Schreinemachers  DMEverson  RB Aspirin use and lung, colon, and breast cancer incidence in a prospective study.  Epidemiology 1994;5138- 146PubMedGoogle ScholarCrossref
19.
Attebo  KMitchell  PSmith  W Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study.  Ophthalmology 1996;103357- 364PubMedGoogle ScholarCrossref
20.
Mitchell  PSmith  WAttebo  KWang  JJ Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study.  Ophthalmology 1995;1021450- 1460PubMedGoogle ScholarCrossref
21.
Wang  JJMitchell  PSimpson  JMCumming  RGSmith  W Visual impairment, age-related cataract, and mortality.  Arch Ophthalmol 2001;1191186- 1190PubMedGoogle ScholarCrossref
22.
Magliano  DLiew  DPater  H  et al.  Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long-term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study.  Aust N Z J Public Health 2003;27649- 653PubMedGoogle ScholarCrossref
23.
Powers  JBall  JAdamson  LDobson  A Effectiveness of the National Death Index for establishing the vital status of older women in the Australian Longitudinal Study on Women’s Health.  Aust N Z J Public Health 2000;24526- 528PubMedGoogle ScholarCrossref
24.
Balkwill  F Cancer and the chemokine network.  Nat Rev Cancer 2004;4540- 550PubMedGoogle ScholarCrossref
25.
Pikarsky  EPorat  RMStein  I  et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer.  Nature 2004;431461- 466PubMedGoogle ScholarCrossref
26.
Helman  NRubenstein  LS The effects of age, sex, and smoking on erythrocytes and leukocytes.  Am J Clin Pathol 1975;6335- 44PubMedGoogle Scholar
27.
Danesh  JCollins  RAppleby  PPeto  R Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.  JAMA 1998;2791477- 1482PubMedGoogle ScholarCrossref
28.
Shankar  AKlein  BEKlein  R Relationship between white blood cell count and incident hypertension.  Am J Hypertens 2004;17233- 239PubMedGoogle ScholarCrossref
29.
Schmidt  MIDuncan  BBSharrett  AR  et al.  Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study.  Lancet 1999;3531649- 1652PubMedGoogle ScholarCrossref
30.
Yu  MCYuan  JM Environmental factors and risk for hepatocellular carcinoma.  Gastroenterology 2004;127 ((suppl 1)) S72- S78PubMedGoogle ScholarCrossref
31.
Lewis  JDDeren  JJLichtenstein  GR Cancer risk in patients with inflammatory bowel disease.  Gastroenterol Clin North Am 1999;28459- 477PubMedGoogle ScholarCrossref
32.
Hanley  AJFesta  AD’Agostino  RB  Jr  et al.  Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.  Diabetes 2004;531773- 1781PubMedGoogle ScholarCrossref
33.
Hammarsten  JHogstedt  B Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.  Blood Press 2004;1347- 55PubMedGoogle ScholarCrossref
34.
Laukkanen  JALaaksonen  DENiskanen  LPukkala  EHakkarainen  ASalonen  JT Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.  Cancer Epidemiol Biomarkers Prev 2004;131646- 1650PubMedGoogle Scholar
35.
Ridker  PMCushman  MStampfer  MJTracy  RPHennekens  CH Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.  N Engl J Med 1997;336973- 979PubMedGoogle ScholarCrossref
Original Investigation
January 23, 2006

Association Between Circulating White Blood Cell Count and Cancer Mortality: A Population-Based Cohort Study

Author Affiliations

Author Affiliations: Division of Epidemiology, Department of Community, Occupational, and Family Medicine and the Centre for Molecular Epidemiology, National University of Singapore, Singapore (Dr Shankar); Centre for Vision Research, Department of Ophthalmology (Drs Wang and Mitchell and Ms Rochtchina), Westmead Millennium Institute (Drs Wang, Kefford, and Mitchell and Ms Rochtchina), and Westmead Institute for Cancer Research (Dr Kefford), University of Sydney, Sydney, Australia; and University of Minnesota Cancer Center, Minneapolis (Dr Yu).

Arch Intern Med. 2006;166(2):188-194. doi:10.1001/archinte.166.2.188
Abstract

Background  Inflammatory processes are implicated in the development and progression of cancer. However, it is not clear whether systemic markers of inflammation predict cancer. We examined the prospective relationship between circulating white blood cell (WBC) count and cancer mortality.

Methods  Population-based cohort study of 3189 individuals, aged 49 to 84 years and free of cancer at the baseline examination (January 1, 1992, to December 31, 1994), in the Blue Mountains region, west of Sydney, Australia. The main outcome of interest was all cancer mortality ascertained from vital status as of December 31, 2001.

Results  Higher WBC count was found to be associated with all cancer mortality. In proportional hazards models adjusting for age, sex, education, body mass index, hematocrit level, alcohol consumption, physical inactivity, smoking, weekly aspirin use, diabetes mellitus or fasting hyperglycemia status, and fasting glucose levels, the multivariable relative risk of all cancer mortality comparing quartile 4 of WBC count ( ≥7400 cells/μL) with quartile 1 (≤5300 cells/μL) was 1.73 (95% confidence interval [CI], 1.18-2.55). In subgroup analyses, the relative risk of cancer mortality comparing quartile 4 of WBC count with quartile 1 was higher among those with diabetes or fasting hyperglycemia (3.03 [95% CI, 1.01-9.15]) than among those with normoglycemia (1.68 [95% CI, 1.12-2.52]). Also, the relative risk of cancer mortality associated with joint exposure to quartile 4 of WBC count and aspirin nonuse was 2.42 (95% CI, 1.46-4.01) compared with their absence.

Conclusion  These data provide new epidemiological evidence of an association between circulating WBC count, a widely available marker of inflammation, and subsequent cancer mortality.

×